Researcher
First Affiliated Hospital of Shihezi University Medical College
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
A descriptive epidemiological analysis and modelling study synthesizing historical Global Burden of Disease data with Bayesian projections to 2050; no intervention trial, no novel mechanism, and projections rest on model assumptions not validated against future outcomes.
AUG 13, 2026 · JOURNAL ARTICLE
Frontiers in Oncology
Single-center retrospective study showing superior PFS and ORR for ICI+chemotherapy versus bevacizumab+chemotherapy in driver gene-negative NSCLC, but limited by retrospective design, unbalanced group sizes, and lack of adjustment for confounders.